Predictors of adalimumab drug survival in psoriasis differ by reason for discontinuation: long‐term results from the Bio‐CAPTURE registry

Publisher: John Wiley & Sons Inc

E-ISSN: 1468-3083|29|3|560-565

ISSN: 0926-9959

Source: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol.29, Iss.3, 2015-03, pp. : 560-565

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content